MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer

Nucleic Acids Research

Volumn 40, Issue 8, 2012, Pages 3689-3703

  Hudson, Robert S ^a   Yi, Ming ^b   Esposito, Dominic ^b   Watkins, Stephanie K ^c   Hurwitz, Arthur A ^c   Yfantis, Harris G ^d   Lee, Dong H ^d   Borin, James F ^e   Naslund, Michael J ^e   Alexander, Richard B ^e   Dorsey, Tiffany H ^a   Stephens, Robert M ^b   Croce, Carlo M ^f   Ambs, Stefan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NCI Frederick   (United States)

^d BALTIMORE VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; F ACTIN; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; MICRORNA 1;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RECURRENCE; CELL CYCLE PROGRESSION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DOWN REGULATION; EPIGENETICS; FOLLOW UP; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METASTASIS; MITOSIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR GENE; TUMOR XENOGRAFT; WESTERN BLOTTING;

CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA REPAIR; EPIGENESIS, GENETIC; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASE INHIBITORS; HUMANS; MALE; MICRORNAS; MITOSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860363146     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1222     Document Type: Article

References (58)

1. Baek, D., Villen, J., Shin, C., Camargo, F.D., Gygi, S.P. and Bartel, D.P. (2008) The impact of microRNAs on protein output. Nature, 455, 64-71.
2. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
3. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261.
4. Volinia, S., Galasso, M., Costinean, S., Tagliavini, L., Gamberoni, G., Drusco, A., Marchesini, J., Mascellani, N., Sana, M.E., Abu, J.R. et al. (2010) Reprogramming of miRNA networks in cancer and leukemia. Genome Res., 20, 589-599.
5. Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K. et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA, 99, 15524-15529.
6. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
7. He, L., He, X., Lim, L.P., de, S.E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
8. Tavazoie, S.F., Alarcon, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P.D., Gerald, W.L. and Massague, J. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451, 147-152.
9. Chang, T.C., Yu, D., Lee, Y.S., Wentzel, E.A., Arking, D.E., West, K.M., Dang, C.V., Thomas-Tikhonenko, A. and Mendell, J.T. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet., 40, 43-50.
10. Varambally, S., Cao, Q., Mani, R.S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K. et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science, 322, 1695-1699.
11. Poliseno, L., Salmena, L., Riccardi, L., Fornari, A., Song, M.S., Hobbs, R.M., Sportoletti, P., Varmeh, S., Egia, A., Fedele, G. et al. (2010) Identification of the miR-106b 25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal., 3, ra29.
12. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
13. Calin, G.A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S.E., Iorio, M.V., Visone, R., Sever, N.I., Fabbri, M. et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 353, 1793-1801.
14. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R.M., Okamoto, A., Yokota, J., Tanaka, T. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
15. Bloomston, M., Frankel, W.L., Petrocca, F., Volinia, S., Alder, H., Hagan, J.P., Liu, C.G., Bhatt, D., Taccioli, C. and Croce, C.M. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 297, 1901-1908.
16. Schetter, A.J., Leung, S.Y., Sohn, J.J., Zanetti, K.A., Bowman, E.D., Yanaihara, N., Yuen, S.T., Chan, T.L., Kwong, D.L., Au, G.K. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
17. Ji, J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S., Ambs, S., Chen, Y., Meltzer, P.S., Croce, C.M. et al. (2009) MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med., 361, 1437-1447.
18. Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA, 101, 2999-3004.
19. Zhang, L., Huang, J., Yang, N., Greshock, J., Megraw, M.S., Giannakakis, A., Liang, S., Naylor, T.L., Barchetti, A., Ward, M.R. et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA, 103, 9136-9141.
20. Lujambio, A., Calin, G.A., Villanueva, A., Ropero, S., Sanchez-Cespedes, M., Blanco, D., Montuenga, L.M., Rossi, S., Nicoloso, M.S., Faller, W.J. et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA, 105, 13556-13561.
21. Sandberg, R., Neilson, J.R., Sarma, A., Sharp, P.A. and Burge, C.B. (2008) Proliferating cells express mRNAs with shortened 30 untranslated regions and fewer microRNA target sites. Science, 320, 1643-1647.
22. Mayr, C. and Bartel, D.P. (2009) Widespread shortening of 30-UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell, 138, 673-684.
23. Chiosea, S., Jelezcova, E., Chandran, U., Acquafondata, M., McHale, T., Sobol, R.W. and Dhir, R. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol., 169, 1812-1820.
24. Porkka, K.P., Pfeiffer, M.J., Waltering, K.K., Vessella, R.L., Tammela, T.L. and Visakorpi, T. (2007) MicroRNA expression profiling in prostate cancer. Cancer Res., 67, 6130-6135.
25. Ozen, M., Creighton, C.J., Ozdemir, M. and Ittmann, M. (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene., 27, 1788-1793.
26. Ambs, S., Prueitt, R.L., Yi, M., Hudson, R.S., Howe, T.M., Petrocca, F., Wallace, T.A., Liu, C.G., Volinia, S., Calin, G.A. et al. (2008) Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res., 68, 6162-6170.
27. Prueitt, R.L., Yi, M., Hudson, R.S., Wallace, T.A., Howe, T.M., Yfantis, H.G., Lee, D.H., Stephens, R.M., Liu, C.G., Calin, G.A. et al. (2008) Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate, 68, 1152-1164.
28. Tong, A.W., Fulgham, P., Jay, C., Chen, P., Khalil, I., Liu, S., Senzer, N., Eklund, A.C., Han, J. and Nemunaitis, J. (2009) MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther., 16, 206-216.
29. Ribas, J., Ni, X., Haffner, M., Wentzel, E.A., Salmasi, A.H., Chowdhury, W.H., Kudrolli, T.A., Yegnasubramanian, S., Luo, J., Rodriguez, R. et al. (2009) miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res., 69, 7165-7169.
30. Szczyrba, J., Loprich, E., Wach, S., Jung, V., Unteregger, G., Barth, S., Grobholz, R., Wieland, W., Stohr, R., Hartmann, A. et al. (2010) The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol. Cancer Res., 8, 529-538.
31. Jung, M., Schaefer, A., Steiner, I., Kempkensteffen, C., Stephan, C., Erbersdobler, A. and Jung, K. (2010) Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin. Chem., 56, 998-1006.
32. Long, Q., Johnson, B.A., Osunkoya, A.O., Lai, Y.H., Zhou, W., Abramovitz, M., Xia, M., Bouzyk, M.B., Nam, R.K., Sugar, L. et al. (2011) Protein-coding and MicroRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Am. J. Pathol., 179, 46-54.
33. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W. and Tuschl, T. (2002) Identification of tissue-specific microRNAs from mouse. Curr. Biol., 12, 735-739.
34. Zhao, Y., Ransom, J.F., Li, A., Vedantham, V., von Drehle, M., Muth, A.N., Tsuchihashi, T., McManus, M.T., Schwartz, R.J. and Srivastava, D. (2007) Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2. Cell, 129, 303-317.
35. Mishima, Y., breu-Goodger, C., Staton, A.A., Stahlhut, C., Shou, C., Cheng, C., Gerstein, M., Enright, A.J. and Giraldez, A.J. (2009) Zebrafish miR-1 and miR-133 shape muscle gene expression and regulate sarcomeric actin organization. Genes Dev., 23, 619-632.
36. Navon, R., Wang, H., Steinfeld, I., Tsalenko, A., Ben-Dor, A. and Yakhini, Z. (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE, 4, e8003.
37. Datta, J., Kutay, H., Nasser, M.W., Nuovo, G.J., Wang, B., Majumder, S., Liu, C.G., Volinia, S., Croce, C.M., Schmittgen, T.D. et al. (2008) Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res., 68, 5049-5058.
38. Nasser, M.W., Datta, J., Nuovo, G., Kutay, H., Motiwala, T., Majumder, S., Wang, B., Suster, S., Jacob, S.T. and Ghoshal, K. (2008) Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem., 283, 33394-33405.
39. Taylor, B.S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B.S., Arora, V.K., Kaushik, P., Cerami, E., Reva, B. et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell, 18, 11-22.
40. Liu, C.G., Calin, G.A., Meloon, B., Gamliel, N., Sevignani, C., Ferracin, M., Dumitru, C.D., Shimizu, M., Zupo, S., Dono, M. et al. (2004) An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl Acad. Sci. USA, 101, 9740-9744.
41. Day, C.P., Carter, J., Bonomi, C., Esposito, D., Crise, B., Ortiz-Conde, B., Hollingshead, M. and Merlino, G. (2009) Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study. Pigment Cell Melanoma Res., 22, 283-295.
42. Yi, M., Horton, J.D., Cohen, J.C., Hobbs, H.H. and Stephens, R.M. (2006) WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics, 7, 30.
43. Wallace, T.A., Prueitt, R.L., Yi, M., Howe, T.M., Gillespie, J.W., Yfantis, H.G., Stephens, R.M., Caporaso, N.E., Loffredo, C.A. and Ambs, S. (2008) Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res., 68, 927-936.
44. Yi, M., Mudunuri, U., Che, A. and Stephens, R.M. (2009) Seeking unique and common biological themes in multiple gene lists or datasets: pathway pattern extraction pipeline for pathway-level comparative analysis. BMC Bioinformatics, 10, 200.
45. Greenberg, N.M., DeMayo, F., Finegold, M.J., Medina, D., Tilley, W.D., Aspinall, J.O., Cunha, G.R., Donjacour, A.A., Matusik, R.J. and Rosen, J.M. (1995) Prostate cancer in a transgenic mouse. Proc. Natl Acad. Sci. USA, 92, 3439-3443.
46. Zaman, M.S., Chen, Y., Deng, G., Shahryari, V., Suh, S.O., Saini, S., Majid, S., Liu, J., Khatri, G., Tanaka, Y. et al. (2010) The functional significance of microRNA-145 in prostate cancer. Br. J. Cancer, 103, 256-264.
47. Lamb, J., Crawford, E.D., Peck, D., Modell, J.W., Blat, I.C., Wrobel, M.J., Lerner, J., Brunet, J.P., Subramanian, A., Ross, K.N. et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
48. Song, G., Zhang, Y. and Wang, L. (2009) MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J. Biol. Chem., 284, 31921-31927.
49. Schreiber, V., Moog-Lutz, C., Regnier, C.H., Chenard, M.P., Boeuf, H., Vonesch, J.L., Tomasetto, C. and Rio, M.C. (1998) Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions. Mol. Med., 4, 675-687.
50. Grunewald, T.G., Kammerer, U., Schulze, E., Schindler, D., Honig, A., Zimmer, M. and Butt, E. (2006) Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp. Cell Res., 312, 974-982.
51. Martens-Uzunova, E.S., Jalava, S.E., Dits, N.F., van Leenders, G.J., Møller, S., Trapman, J., Bangma, C.H., Litman, T., Visakorpi, T. and Jenster, G. (2012) Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene, 31, 978-991.
52. Yan, D., Dong, X.E., Chen, X., Wang, L., Lu, C., Wang, J., Qu, J. and Tu, L. (2009) MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J. Biol. Chem., 284, 29596-29604.
53. Lal, A., Pan, Y., Navarro, F., Dykxhoorn, D.M., Moreau, L., Meire, E., Bentwich, Z., Lieberman, J. and Chowdhury, D. (2009) miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat. Struct. Mol. Biol., 16, 492-498.
54. Sood, P., Krek, A., Zavolan, M., Macino, G. and Rajewsky, N. (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc. Natl Acad. Sci. USA, 103, 2746-2751.
55. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
56. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J. and Lotvall, J.O. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 9, 654-659.
57. Halkidou, K., Cook, S., Leung, H.Y., Neal, D.E. and Robson, C.N. (2004) Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate. Eur. Urol., 45, 382-389.
58. Wilson, A.J., Byun, D.S., Nasser, S., Murray, L.B., Ayyanar, K., Arango, D., Figueroa, M., Melnick, A., Kao, G.D., Augenlicht, L.H. et al. (2008) HDAC4 promotes growth of colon cancer cells via repression of p21. Mol. Biol. Cell, 19, 4062-4075.